|
|
Volumn 12, Issue 10, 2012, Pages 1337-1345
|
|
Why do targeted agents not work in the adjuvant setting in colon cancer?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
CETUXIMAB;
MONOCLONAL ANTIBODY;
ANIMAL;
COLON TUMOR;
HUMAN;
MOLECULARLY TARGETED THERAPY;
PHASE 3 CLINICAL TRIAL (TOPIC);
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REVIEW;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS, PHASE III AS TOPIC;
COLONIC NEOPLASMS;
HUMANS;
MOLECULAR TARGETED THERAPY;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 84877087475
PISSN: None
EISSN: 17448328
Source Type: Journal
DOI: 10.1586/era.12.111 Document Type: Review |
|
Times cited : (12)
|
|
References (0)
|
